N-[(1R,3S)-3-(3-aminopyrrolidin-1-yl)cyclohexyl]-5-chloro-4-(1H-indol-3-yl)pyrimidin-2-amine
C22H27ClN6 — CID 135255427
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1R,3S)-3-(3-aminopyrrolidin-1-yl)cyclohexyl]-5-chloro-4-(1H-indol-3-yl)pyrimidin-2-amine
N-[(1R,3S)-3-(3-aminopyrrolidin-1-yl)cyclohexyl]-5-chloro-4-(1H-indol-3-yl)pyrimidin-2-amine (PubChem CID 135255427) has the molecular formula C22H27ClN6 and a molecular weight of 410.95 g/mol. Its IUPAC name is N-[(1R,3S)-3-(3-aminopyrrolidin-1-yl)cyclohexyl]-5-chloro-4-(1H-indol-3-yl)pyrimidin-2-amine.
Molecular Properties
| Compound Name | N-[(1R,3S)-3-(3-aminopyrrolidin-1-yl)cyclohexyl]-5-chloro-4-(1H-indol-3-yl)pyrimidin-2-amine |
|---|---|
| PubChem CID | 135255427 |
| Molecular Formula | C22H27ClN6 |
| Molecular Weight | 410.95 g/mol |
| Exact Mass | 410.20 |
| IUPAC Name | N-[(1R,3S)-3-(3-aminopyrrolidin-1-yl)cyclohexyl]-5-chloro-4-(1H-indol-3-yl)pyrimidin-2-amine |
| SMILES | NC1CCN([C@H]2CCC[C@@H](Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)C2)C1 |
| InChI | InChI=1S/C22H27ClN6/c23-19-12-26-22(28-21(19)18-11-25-20-7-2-1-6-17(18)20)27-15-4-3-5-16(10-15)29-9-8-14(24)13-29/h1-2,6-7,11-12,14-16,25H,3-5,8-10,13,24H2,(H,26,27,28)/t14?,15-,16+/m1/s1 |
| InChIKey | NBMZTUYDJSZOKP-JAIYHHTPSA-N |
| XLogP | 4.03 |
| TPSA | 82.86 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 410.95 |
| LogP ≤ 5 | 4.03 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135255427 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.